Leveling up: Treating Uptake as Endogenous May Increase the Value of Screening Programs
Author
Abstract
Suggested Citation
DOI: 10.1177/0272989X251319794
Download full text from publisher
References listed on IDEAS
- Karen M. Kuntz & Sue J. Goldie, 2002. "Assessing the Sensitivity of Decision-Analytic Results to Unobserved Markers of Risk: Defining the Effects of Heterogeneity Bias," Medical Decision Making, , vol. 22(3), pages 218-227, June.
- Chapple, Alison & Ziebland, Sue & Hewitson, Paul & McPherson, Ann, 2008. "What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): A qualitative study," Social Science & Medicine, Elsevier, vol. 66(12), pages 2425-2435, June.
- Anirban Basu & David Meltzer, 2007. "Value of Information on Preference Heterogeneity and Individualized Care," Medical Decision Making, , vol. 27(2), pages 112-127, March.
- Fern Terris‐Prestholt & Matthew Quaife & Peter Vickerman, 2016. "Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 116-123, February.
- David D. Kim & Anirban Basu, 2017. "New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives," Medical Decision Making, , vol. 37(8), pages 930-941, November.
- Charles E. Phelps & Alvin I. Mushlin, 1988. "Focusing Technology Assessment Using Medical Decision Theory," Medical Decision Making, , vol. 8(4), pages 279-289, December.
- Fern Terris‐Prestholt & Matthew Quaife & Peter Vickerman, 2016. "Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments," Health Economics, John Wiley & Sons, Ltd., vol. 25, pages 116-123, February.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Michael S. Willis & Andreas Nilsson & Cheryl A. Neslusan, 2025. "A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care," PharmacoEconomics, Springer, vol. 43(6), pages 601-616, June.
- Charles F. Manski, 2018. "Reasonable patient care under uncertainty," Health Economics, John Wiley & Sons, Ltd., vol. 27(10), pages 1397-1421, October.
- Charles F. Manski, 2022.
"Patient‐centered appraisal of race‐free clinical risk assessment,"
Health Economics, John Wiley & Sons, Ltd., vol. 31(10), pages 2109-2114, October.
- Charles F. Manski, 2021. "Patient-Centered Appraisal of Race-Free Clinical Risk Assessment," Papers 2112.01639, arXiv.org, revised Feb 2022.
- Chandoevwit, Worawan & Wasi, Nada, 2020.
"Incorporating discrete choice experiments into policy decisions: Case of designing public long-term care insurance,"
Social Science & Medicine, Elsevier, vol. 258(C).
- Worawan Chandoevwit & Nada Wasi, 2020. "Incorporating Discrete Choice Experiments into Policy Decisions: Case of Designing Public Long-Term Care Insurance," PIER Discussion Papers 134, Puey Ungphakorn Institute for Economic Research.
- Charles F. Manski, 2023.
"Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose,"
NBER Working Papers
31305, National Bureau of Economic Research, Inc.
- Charles F. Manski, 2023. "Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose," Papers 2305.17206, arXiv.org.
- Matthew Quaife & Fern Terris-Prestholt & Gian Luca Di Tanna & Peter Vickerman, 2018. "How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1053-1066, November.
- Manuel Antonio Espinoza & Andrea Manca & Karl Claxton & Mark Sculpher, 2018. "Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system," Health Economics, John Wiley & Sons, Ltd., vol. 27(2), pages 28-40, February.
- Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
- Hui Zhang & Christian Wernz & Danny R. Hughes, 2018. "Modeling and designing health care payment innovations for medical imaging," Health Care Management Science, Springer, vol. 21(1), pages 37-51, March.
- Charles F. Manski, 2020. "Towards Reasonable Patient Care Under Uncertainty," Contemporary Economic Policy, Western Economic Association International, vol. 38(2), pages 227-245, April.
- Charles E. Phelps, 1997. "Good Technologies Gone Bad," Medical Decision Making, , vol. 17(1), pages 107-117, February.
- David Bardey & Philippe de Donder & Vera Zaporozhets, 2024.
"The health technology assessment approach of the economic value of diagnostic tests: a literature review,"
Working Papers
hal-04472485, HAL.
- David Bardey & Philippe de Donder & Vera Zaporozhets, 2025. "The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests : A Literature Review," Post-Print hal-05024927, HAL.
- David Bardey & Philippe De Donder & Vera Zaporozhets, 2024. "The Health Technology Assessment Approach of The Economic Value of Diagnostic Test: A Literature Review," Documentos CEDE 21041, Universidad de los Andes, Facultad de Economía, CEDE.
- Bardey, David & De Donder, Philippe & Zaporozhets, Vera, 2024. "The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review," TSE Working Papers 24-1508, Toulouse School of Economics (TSE), revised 10 Jun 2026.
- Dominic Hodgkin & Joanna Volpe‐Vartanian & Elizabeth L. Merrick & Constance M. Horgan & Andrew A. Nierenberg & Richard G. Frank & Sue Lee, 2012. "Customization in prescribing for bipolar disorder," Health Economics, John Wiley & Sons, Ltd., vol. 21(6), pages 653-668, June.
- Jan Ostermann & Derek S. Brown & Esther W. Bekker-Grob & Axel C. Mühlbacher & Shelby D. Reed, 2017. "Preferences for Health Interventions: Improving Uptake, Adherence, and Efficiency," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 10(4), pages 511-514, August.
- Jeremy D. Goldhaber-Fiebert & Hawre Jalal & Fernando Alarid-Escudero, 2025. "Microsimulation Estimates of Decision Uncertainty and Value of Information Are Biased but Consistent," Medical Decision Making, , vol. 45(2), pages 127-142, February.
- Charles F. Manski, 2016. "Credible Ecological Inference for Personalized Medicine: Formalizing Clinical Judgment," NBER Working Papers 22643, National Bureau of Economic Research, Inc.
- Anna Heath & Petros Pechlivanoglou, 2022. "Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity," Medical Decision Making, , vol. 42(5), pages 649-660, July.
- Olivier Ethgen & Baudouin Standaert, 2012. "Population–versus Cohort–Based Modelling Approaches," PharmacoEconomics, Springer, vol. 30(3), pages 171-181, March.
- Kwok Lung Fan & Yee Lam Elim Thompson & Weijie Chen & Craig K. Abbey & Frank W. Samuelson, 2026. "Use of Expected Utility to Evaluate Artificial Intelligence–Enabled Rule-out Devices for Mammography Screening," Medical Decision Making, , vol. 46(3), pages 321-333, April.
- Grace Hui-Min Wu & Shu-Hui Chang & Tony Hsiu-Hsi Chen, 2008. "A Bayesian Random-Effects Markov Model for Tumor Progression in Women with a Family History of Breast Cancer," Biometrics, The International Biometric Society, vol. 64(4), pages 1231-1237, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:45:y:2025:i:3:p:318-331. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.
Printed from https://ideas.repec.org/a/sae/medema/v45y2025i3p318-331.html